Ghisallo Capital Management LLC
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 1825214
Boston, MA
Position in DMII
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,477,500
+$52,500 QoQ
Shares Held
750,000
0.0% QoQ
Ownership
1.18%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMII Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Mar 31, 2026Ghisallo Capital Management LLC holds $198,823,550 across 49 Shell Companies names. DMII ranks #9 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRSP |
Rice Acquisition Corp 3
|
1,000,000 | $10,310,000 | |
| 2 | TACH |
Titan Acquisition Corp.
|
1,000,000 | $10,290,000 | |
| 3 | NPAC |
New Providence Acquisition Corp. III/Cayman
|
1,000,000 | $10,260,000 | |
| 4 | BCSS |
Bain Capital GSS Investment Corp.
|
1,000,000 | $10,112,000 | |
| 5 | KBON |
Karbon Capital Partners Corp.
|
1,000,000 | $10,060,000 | |
| 6 | NTWO |
Newbury Street II Acquisition Corp
|
950,000 | $9,984,500 | |
| 7 | ALDF |
Aldel Financial II Inc.
|
900,000 | $9,504,000 | |
| 8 | ATII |
Archimedes Tech SPAC Partners II Co.
|
800,000 | $8,328,000 |
All Filings in DMII
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,477,500 | 750,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,425,000 | 750,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||